Comments Off on Roche’s Genentech Gets FDA Approval for Lung Cancer Treatment
Genetech, a member of the Roche Group, had announced that U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment of [...]
Comments Off on World’s First Lung Cancer Vaccine is Being Developed by UK Researchers
Lung cancer is the deadliest form of cancers all around the world including Britain. Every year, around 50,000 cases and 35,000 deaths of patients with lung [...]
Comments Off on New Deep Learning Tool To Predict Brain Metastasis In Lung Cancer Patients
Lung cancer is the leading cause of deaths from cancers worldwide. Most lung cancers are characterized as non-small cell lung cancer and about 30% of patients [...]
Comments Off on Gene Signature to Help Patients with NSCLC
Lung cancer is the leading cause of cancer mortality in the United States and all across the world. Non-small cell lung cancer (NSCLC) accounts for about 80 to [...]
Comments Off on Targeted Therapy Better than Immunotherapy in Some Patients with NSCLC
Non-small cell lung cancer continues to remain one of the main reasons behind cancer related deaths all across the world. Continuous studies and research works [...]
Comments Off on SABR For Inoperable Early Stage NSCLC
Stereotactic Ablative Radiotherapy (SABR) is an external beam treatment modality that delivers high precision large doses of radiation. In simple words, it is [...]
Comments Off on Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer
According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy [...]
Comments Off on Research Suggests that a type of allergy medicine might help with lung cancer Treatment
The researchers at the Icahn School of Medicine at Mount Sinai have found an allergy pathway that, when blocked, could unlease anti-tumor immunity in mouse [...]
Comments Off on Dizal Published New Pivotal Phase II Trial Data on Sunvozertinib in NSCLC
Shanghai-based biopharmaceutical company, Dizal, has published new Pivotal Phase II Trial Data on sunvozertinib in non-small cell lung cancer (NSCLC). [...]
Comments Off on Research Suggests Allergy Medicine may Treat Lung Cancer
Icahn School of Medicine researchers have reported that they discovered an ingredient in allergy medicine that can reduce lung cancer tumors. In their study, [...]
Comments Off on New Study Finds A Way To Stop Key Lung Cancer Spread Protein
Lung cancer is among the most common types of cancers prevailing all over the world. A new study by Tulane University has found a molecular pathway to stop [...]
Comments Off on Durvalumab for Treatment of Lung Cancer
Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab [...]